{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:13:52Z","timestamp":1777929232122,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Anti-phospholipid syndrome (APS) is systemic autoimmune disorder defined as presence of anti-phospholipid antibodies with multiple obstetric complications. miR-146a-5P and miR-155-5P regulate APS and its associated inflammatory cytokines.\n                    <jats:bold>Purpose:<\/jats:bold>\n                    Our aim is to study expression levels of miR-146a-5p, miR-155-5p and pro-inflammatory cytokine interleukin-8 (IL-8) among pregnant females having APS.\n                    <jats:bold>Research design:<\/jats:bold>\n                    It is a case-control study.\n                    <jats:bold>Data Collection and Analysis:<\/jats:bold>\n                    Case group consisted of 50 pregnant women having APS. Control group consisted of 50 healthy pregnant women. Expression levels of miR-146a-5p and miR-155-5p were determined by quantitative reverse transcription polymerase chain reaction method (qPCR). IL-8 levels were determined using enzyme-linked immunosorbent assay (ELISA).\n                    <jats:bold>Results:<\/jats:bold>\n                    miR-146a-5p (mean \u00b1 SD), p value (confidence interval (CI)) among APS group versus Control group = (0.95 \u00b1 0.7) versus (0.27 \u00b1 0.4); 0.01 (0.44-0.90). miR-146a-5p had area under curve (AUC) of 0.813, sensitivity 66% &amp; specificity 86%. miR-155-5p (mean \u00b1 SD); p value (CI) among APS group versus Control group = (0.57 \u00b1 1.0) versus (0.48 \u00b1 0.7); 0.60 (\u22120.25\u22120.43). miR-155-5p had (AUC) of 0.582, sensitivity 92% &amp; specificity 40%. (mean \u00b1 SD); P value (CI) of IL-8 in APS group versus control group = (6.11 \u00b1 1.2) versus (5.19 \u00b1 0.5); CI(\u22120.36\u2212 0.52),\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    &lt; .001.\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    miR-146a-5p significantly higher among APS group. IL-8 significantly more predominates among APS group. Alterations in miRNA expression are involved in thrombosis associated pregnancy complications.\n                  <\/jats:p>","DOI":"10.1177\/09612033261430573","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:00:04Z","timestamp":1772031604000},"page":"572-580","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression levels of miR-146a-5p, miR-155-5p and the pro-inflammatory cytokine IL-8 in pregnant women with anti-phospholipid syndrome"],"prefix":"10.1177","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4486-7234","authenticated-orcid":false,"given":"Mai M.","family":"Shaker","sequence":"first","affiliation":[{"name":"National Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesma M.","family":"Elaraby","sequence":"additional","affiliation":[{"name":"National Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taghreed A.","family":"Shalabi","sequence":"additional","affiliation":[{"name":"National Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"crossref","unstructured":"Tan Y Liu Q Li Z et al. Pyroptosis-triggered pathogenesis: new insights on antiphospholipid syndrome. Front Immunol; 14: 1-12. https:\/\/doi.org\/10.3389\/fimmu.2023.1155222 Epub ahead of print 2023.","DOI":"10.3389\/fimmu.2023.1155222"},{"key":"e_1_3_8_3_2","doi-asserted-by":"crossref","unstructured":"Luo X Pan C Guo X et al. Methylation mediated silencing of miR-155 suppresses the development of preeclampsia in vitro and in vivo by targeting FOXO3. Mediat Inflamm 2022; 26: 1-20. https:\/\/doi.org\/10.1155\/2022\/4250621 Epub ahead of print 2022.","DOI":"10.1155\/2022\/4250621"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"e_1_3_8_5_2","doi-asserted-by":"crossref","unstructured":"Erton ZB Sevim E De Jes\u00fas GR et al. Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository (\u20ac registry\u2019). Lupus Sci Med; 9: 1-10. https:\/\/doi.org\/10.1136\/lupus-2021-000633 Epub ahead of print 2022.","DOI":"10.1136\/lupus-2021-000633"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1055\/a-1701-2809"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.824775"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13761"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1697982"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead633"},{"key":"e_1_3_8_11_2","doi-asserted-by":"crossref","first-page":"e069717","DOI":"10.1136\/bmj-2021-069717","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight JS","year":"2023","unstructured":"Knight JS, Branch DW, Ortel TL. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ 2023; 380: e069717. https:\/\/doi.org\/10.1136\/bmj-2021-069717 Epub ahead of print.","journal-title":"BMJ"},{"key":"e_1_3_8_12_2","first-page":"425","article-title":"Placenta microRNA profile of patient with obstetric antiphospholipid syndrome","volume":"45","author":"Mohamad MA","year":"2023","unstructured":"Mohamad MA, Ahmad Asnawi AW, Suhiman MS, et al. Placenta microRNA profile of patient with obstetric antiphospholipid syndrome. Malays J Pathol 2023; 45: 425\u2013440.","journal-title":"Malays J Pathol"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2020.05.002"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep31375"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062076"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaw027"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00764"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key159"},{"key":"e_1_3_8_19_2","first-page":"3078","article-title":"MicroRNA-146a inhibits NF-\u03baB activation and pro-inflammatory cytokine production by regulating IRAK1 expression in THP-1 cells","volume":"18","author":"Zhou C","year":"2019","unstructured":"Zhou C, Zhao L, Wang K, et al. MicroRNA-146a inhibits NF-\u03baB activation and pro-inflammatory cytokine production by regulating IRAK1 expression in THP-1 cells. Exp Ther Med 2019; 18: 3078\u20133084. https:\/\/doi.org\/10.3892\/etm.2019.7881 Epub ahead of print.","journal-title":"Exp Ther Med"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2019.1699107"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147350"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094689"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02179-5"},{"key":"e_1_3_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2011.01.007"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-01125-4"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092003"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-021-10173-5"},{"key":"e_1_3_8_28_2","first-page":"217","article-title":"Whole peripheral blood miR-146a and miR-155 expression levels in systemic lupus erythematosus patients","volume":"2018","author":"Shumnalieva R","year":"2018","unstructured":"Shumnalieva R, Kachakova D, Shoumnalieva-Ivanova V, et al. Whole peripheral blood miR-146a and miR-155 expression levels in systemic lupus erythematosus patients. Acta Reumatol Port 2018; 2018: 217\u2013225.","journal-title":"Acta Reumatol Port"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155828"},{"key":"e_1_3_8_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tea.2011.0634"},{"key":"e_1_3_8_31_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016010045"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033261430573","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09612033261430573","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033261430573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:29:50Z","timestamp":1777678190000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09612033261430573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1177\/09612033261430573"],"URL":"https:\/\/doi.org\/10.1177\/09612033261430573","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}